Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
about
European guidance for the diagnosis and management of osteoporosis in postmenopausal womenEffect of calcitonin on bone and connective tissue metabolism in hemiplegic patients: a two-year prospective study.The role of SERMs in the management of postmenopausal osteoporosis.Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.Calcium, dairy products and osteoporosis.A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects.Comparing therapies for postmenopausal osteoporosis prevention and treatment.Bone loss in spinal cord-injured patients: from physiopathology to therapy.Issues concerning the use of hormone replacement therapy and risk of fracture: a population-based, nested case-control study.European guidance for the diagnosis and management of osteoporosis in postmenopausal women.Progress in osteoporosis and fracture prevention: focus on postmenopausal women.Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.Biochemical markers of bone turnover. A review.Prevention of fractures in the elderly. A review.Micronutrients and exercise: anti-oxidants and minerals.Osteoporosis. Current pharmacologic options for prevention and treatment.How well do investigators estimate results in advance? A methodological study from a multinational epidemiological survey on hip fracture risks.The effectiveness of bone density measurement and associated treatments for prevention of fractures. An international collaborative review.Patient-specific in silico models can quantify primary implant stability in elderly human bone.[Hip fracture incidence in an urban area in Northeast Brazil].
P2860
Q24612411-47B7CDF3-78B3-4C11-9ECA-4D7ABEF8FB9DQ33178938-69763AF6-17DC-4EEB-A604-D01496FFAC64Q33757760-14BECCC2-0247-420A-9952-1A965B94066BQ33805259-65E55B80-E647-4C84-8576-607094A55E8EQ33887924-EBF3136D-9976-4E53-9603-2F76CFDFE404Q34573282-2D4E89A0-E63C-4757-8511-F85FCA5427D2Q35112397-EA7B89C2-453A-4B14-88D3-4DD1DDBB5A1CQ36255761-6B153020-E43F-4306-B69F-237FE3524F9DQ36535984-279546F5-172C-447F-BD9D-59070CC85A9FQ37037296-CFCE068F-CE41-409D-B784-FE1847F6C9FBQ37453973-B9A2046D-C66C-496C-BB5D-29D480BD2D9CQ38806177-504B4FD8-4130-4710-89A2-8960626D3D53Q40483632-4DF14F70-9F53-48EF-A218-FFC4D87611DCQ40597874-1E8D7188-C27F-4BFD-92E2-52B0BBEE3B38Q41192905-208B4E98-3FDA-4E0B-83A6-5B6F0929F63DQ41329621-028B9523-DF8B-4F2F-A3C0-ADF74D417692Q43911592-2A88AE06-B419-4C43-A049-911867809F0FQ48014983-FFD51A94-A2B2-4220-9CDF-6571FF04255CQ50215843-C2924E81-AB32-4AA5-9ECC-604BD2ED0923Q50760664-DF81AD89-9A73-45BF-B0EE-4EFB5D3A007C
P2860
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@ast
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@en
type
label
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@ast
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@en
prefLabel
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@ast
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@en
P2093
P2860
P1433
P1476
Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture.
@en
P2093
Allander E
Gullberg B
Lopes Vaz AA
Lyritis GP
Mazzuoli G
P2860
P304
P356
10.1136/BMJ.305.6862.1124
P407
P577
1992-11-01T00:00:00Z